Mazzaferri E L, Robyn J
Department of Internal Medicine, Ohio State University, Columbus, USA.
Otolaryngol Clin North Am. 1996 Aug;29(4):637-62.
This article identifies the important prognostic factors that determine outcome and medical management of papillary and follicular thyroid cancer. It summarizes current trends in the use of radioactive iodine (131I) and gives explicit advice on its use in the treatment of these cancers. Preparation, dosimetry, and complication of therapy are discussed in detail. Follow-up with measurement of serum thyroglobulin concentrations and subsequent treatment with thyroid hormone is reviewed.
本文确定了决定乳头状和滤泡状甲状腺癌预后及医疗管理的重要预后因素。总结了放射性碘（131I）使用的当前趋势，并就其在这些癌症治疗中的应用给出了明确建议。详细讨论了治疗的准备、剂量测定和并发症。对血清甲状腺球蛋白浓度测量的随访及随后的甲状腺激素治疗进行了综述。
